NCT06385665

Brief Summary

The goal of this clinical trial is to learn about companionship needs in breast cancer patients who are pathologically or cytologically diagnosed as cancer, are alive with the tumor, and have TNM clinical stage IV. The main questions it aims to answer are:

  1. 1.Patients with advanced breast cancer need family companionship
  2. 2.Analyze and study the reasons and factors that affect the physical and mental impact of effective family companionship on patients with advanced breast cancer Participants will be divided into a companion group and a non-accompaniment group. Patients in the companion group are given graded companion intervention methods. A comparison group: Researchers will compare a non-accompaniment group to see if the physical and mental impact of companionship on patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
304

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

April 22, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 26, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 26, 2024

Status Verified

December 1, 2023

Enrollment Period

Same day

First QC Date

December 26, 2023

Last Update Submit

April 25, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline meatal state on GAD-7 at Week 48.

    The GAD-7 is a validated, self-reported instrument assessing average mental state intensify over the past 24 hour period. Possible scores range from 0 to 21.Change = (Week 48 Score - Baseline Score)

    Baseline and Week 48

  • Change from Baseline physical state on kps at Week 48.

    The kps is a validated, self-reported instrument assessing physical state average intensify over the past 24 hour period. Possible scores range from 0 to 100.Change = (Week 48 Score - Baseline Score)

    Baseline and Week 48

Study Arms (2)

accompanying group

EXPERIMENTAL
Behavioral: Graded companionship

non-accompanied group

NO INTERVENTION

Interventions

Accompanying levels are divided into beginner, intermediate and advanced

accompanying group

Eligibility Criteria

Age21 Years - 72 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer patients who are pathologically or cytologically diagnosed as cancer
  • TNM clinical stage IV

You may not qualify if:

  • Terminal cancer patients who are mentally ill or confused and refuse to participate in the survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, 430022, China

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Deyin Hu, PhD

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

xin Peng, Postgraduate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Deputy chief nurse

Study Record Dates

First Submitted

December 26, 2023

First Posted

April 26, 2024

Study Start

April 22, 2024

Primary Completion

April 22, 2024

Study Completion

December 31, 2024

Last Updated

April 26, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Locations